Study Stopped
The sctrict inclusion and exclusion criteria made the study unfeasible. No patients were enrolled.
Effect of Shock-wave Therapy on the Resorption and Bone Formation in Maxillary Postextraction Sockets
Shockwave
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The extracorporeal shock wave therapy (ESWT) has shown good results in bones and soft tissues of the lower and upper extremities such as: pseudoarthrosis, promoting bone formation of delayed or nonunion fractures, tendinopathies, fascitis and even in vascular pathologies. The investigators main hypothesis is that the application of extracorporeal shock wave therapy (ESWT) in the residual alveolar bone after an extraction of an anterior upper maxillary tooth should prevent further residual alveolar bone resorption and will enhance vital bone formation. The investigators null hypothesis is that applying extracorporeal shock wave therapy (ESWT) in the residual alveolar bone after an extraction of an anterior upper maxillary tooth has no influence in the alveolar bone remodeling process. Therefore, the investigators main objective is to evaluate the efficacy of the ESWT in the prevention of alveolar bone resorption after an extraction with a volumetric exam through computer tomographies (CT) analysis. The investigators secondary objective is to determine the effect of ESWT in the internal bone healing process of these postextraction alveolar sockets, measuring the bone density in the CT (Hounsfield units) and the histomorphometric exam. Methodology: randomized and open clinical trial with 20 patients (10 per group: with or without ESWT treatment) that comply the inclusion and exclusion criteria. In the first appointment the tooth extraction will be performed, while in the second visit (two weeks later), CT scan will be made to all patients and ESWT will be applied in the experimental group. Finally, in the third visit (ten weeks later), a new CT scan will be done and an implant will be placed in the zone taking previously a bone sample with a trephine bur. The expected results are an improvement in the quantity and quality of the alveolar bone before the implant placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 11, 2014
CompletedFirst Posted
Study publicly available on registry
April 2, 2020
CompletedApril 2, 2020
March 1, 2020
2 months
December 11, 2014
April 1, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Bone volume
Measured in Cone Beam Computer Tomography
10 weeks
Histomorphometry
10 weeks
Study Arms (2)
Shockwave therapy
EXPERIMENTALAfter dental extraction, a shockwave therapy will be applied to the area.
Control
NO INTERVENTIONAfter dental extraction, no treatment will be applied
Interventions
A shockwave therapy device will be applied in the alveolar socket area of a maxillary tooth, 2 weeks after tooth extraction was performed.
Eligibility Criteria
You may qualify if:
- Ages between 18 - 65 years old.
- Non-smoking patients.
- Patients committed to rehabilitate the extraction socket with an implant.
- Lack of pathology in the surrounding area.
- Cooperative patients with serious commitment to follow the investigator's postoperative visits, who must sign the informed consent.
- Patients that need a conventional anterior maxillary single tooth extraction.
You may not qualify if:
- Systemic illnesses (ASA III or above) that could contraindicate a surgical intervention or modify the wound healing.
- Patients with cardiopathies.
- Patients taking hormones, calcium or oral or endovenous bisphosphonates.
- Patients with uncontrolled periodontitis / periimplantitis.
- Smokers.
- Patients with implant/s in the upper maxilla.
- Surgical extractions that require rising a flap or ostectomy.
- Bone defects larger of 2 mms in alveolar sockets due to cortical bone defect or resorption, fenestrations or/and dehiscences.
- Guided bone regeneration need.
- Periapical radiolucency larger than 2-3 mms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rui Figueiredolead
- MTS Europe GmbH (sponsor)collaborator
Study Sites (1)
Hospital Odontologic
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rui Rui, DDS, MS, PhD
University of Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor; IDIBELL researcher
Study Record Dates
First Submitted
December 11, 2014
First Posted
April 2, 2020
Study Start
October 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
April 2, 2020
Record last verified: 2020-03